Concepedia

Author

Lloyd R. Kelland

Institute of Cancer Research

Also Known As

L R Kelland, L.R. Kelland, Lloyd R. Kelland

11

Publications

982

Citations

10

H-Index

26

Concepts

All Affiliations

Institute of Cancer Research
LR

About

Lloyd R. Kelland is an author at Institute of Cancer Research specializing in medicine, cancer therapeutics, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

871

2

Cell Biology

5

5

495

3

Public Health

1

1

94

4

Molecular Biology

1

1

20

5

Obstetrics

1

1

30

Lloyd R. Kelland

×

10

Publications

982

Citations

10

H-Index

YearCitations

Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.

Lloyd R. Kelland, G Abel, Mark J. McKeage,

PubMed

1993

224

Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines.

Lloyd R. Kelland, Barry A. Murrer, G Abel,

PubMed

1992

168

Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and-resistant human ovarian carcinoma cell lines

Lloyd R. Kelland, G Abel

Cancer Chemotherapy and Pharmacology

1992

138

Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.

Lloyd R. Kelland, Prakash Mistry, G Abel,

PubMed

1992

124

Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.

Lloyd R. Kelland, Prakash Mistry, G Abel,

PubMed

1992

94

Synthesis and in Vitro and in Vivo Antitumor Activity of a Series of Trans Platinum Antitumor Complexes

Lloyd R. Kelland, F. J. Barnard, I. G. Evans,

Journal of Medicinal Chemistry

1995

91

Sensitivity to novel platinum compounds of panels of human lung cancer cell lines with acquired and inherent resistance to cisplatin

P R Twentyman, K A Wright, Prakash Mistry,

Lung Cancer

1993

79

Characterisation of theP53 status, BCL-2 expression and radiation and platinum drug sensitivity of a panel of human ovarian cancer cell lines

Katharine Pestell, Clare J. Medlow, Jenny Titley,

International Journal of Cancer

1998

30

Platinum coordination complexes which circumvent cisplatin resistance

Ken R. Harrap, Lloyd R. Kelland, Mervyn Jones,

Advances in Enzyme Regulation

1991

20

KW-2149 (7-N-[2-[Y-L-glutamylamino]ethyldithioethyl]mitomycin C) a new mitomycin c analogue activated by serum

John R. Masters, Richard J. Know, John A. Hartley,

Biochemical Pharmacology

1997

14

Page 1